Related Experiment Video
Updated: Aug 9, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Endometrial carcinosarcoma: a poor prognosis debut with favourable therapeutic outcome
María Fernanda Toro-Wills1, Angelina Álvarez-Londoño2, Abraham Hernández-Blanquisett3
1Department of Gynecology, Centro Hospitalario Serena del Mar, Cartagena 130001, Colombia.
Abstract:
Endometrial carcinosarcoma (ECS) is a rare, highly aggressive disease characterised by a biphasic growth of malignant epithelial (carcinomatous) and mesenchymal (sarcomatous) components. Clinically, it cannot be distinguished from endometrial carcinoma or uterine sarcoma. The definitive diagnosis can only be made based on histological examination and immunohistochemistry. To date, there aren't standardised treatment protocols for its management. We report a case of a 73-year-old patient who presented postmenopausal abnormal uterine bleeding and was diagnosed with ECS. A non-conventional treatment approach was conducted with favourable oncological outcomes.

